This targeted approach has proven effective in identifying pathogenic mutations in familial neurodegenerative disorders, such as the C9orf72 repeat expansion in ALS and frontotemporal dementia (FTD) [66]. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.